A

Affimed

154 employees

Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Therapeutics
Medical
Clinical Trials

Date founded

2000

Funding rounds raised

Total raised

$21M

from 8 investors over 8 rounds

A

Affimed raised $21M on October 1, 2015

Investors: Aeris Capital AG

A

Affimed raised $3M on January 7, 2015

Investors: Federal Ministry of Education and Research, Germany

A

Affimed raised $16M on September 2, 2014

Investors: BioMedPartners, OrbiMed Advisors, EQT Life Sciences, Novo Holdings and Aeris Capital AG

A

Affimed raised $14M on September 2, 2014

Investors: Perceptive Advisors

FAQ